Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancers (NSCLC) account for 85–90% of all lung cancers. As drug resistance critically impairs chemotherapy effectiveness, there is great need to identify new therapeutic targets. The aims of this study were to investigate the prognostic and therapeutic potential of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434762/
https://www.ncbi.nlm.nih.gov/pubmed/32439936
http://dx.doi.org/10.1038/s41416-020-0899-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434762/
https://www.ncbi.nlm.nih.gov/pubmed/32439936
http://dx.doi.org/10.1038/s41416-020-0899-2

Ejemplares similares